Administration of 6-gingerol greatly enhances the number of tumor-infiltrating lymphocytes in murine tumors

International Journal of Cancer

Volumn 130, Issue 11, 2012, Pages 2618-2628

  Ju, Seong A ^a   Park, Sang Min ^a   Lee, Yea Sol ^a   Bae, Jun Hyeong ^b   Yu, Rina ^a   An, Won G ^c   Suh, Jae Hee ^d   Kim, Byung Sam ^a  

^a University of Ulsan   (South Korea)

^b Munsu High School   (South Korea)

^c Pusan National University   (South Korea)

^d Ulsan University College of Medicine   (South Korea)

Author keywords

6 gingerol; CD8 T cell; chemokine; tumor immunotherapy; tumor infiltrating lymphocytes

Indexed keywords

(6) GINGEROL; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER LOCALIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL ISOLATION; CELL LABELING; CELL SPECIFICITY; CELL TRANSFER; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG MECHANISM; FEMALE; KIDNEY CARCINOMA; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUMOR ASSOCIATED LEUKOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATECHOLS; CD8-POSITIVE T-LYMPHOCYTES; FATTY ALCOHOLS; FEMALE; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CCR5; RECEPTORS, CXCR3; RECEPTORS, CXCR5;

EID: 84859159252     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26316     Document Type: Article

References (45)

1. Yu R, Fujio K, Tahara H, Araki Y, Yamamoto K,. Clonal dynamics of tumor-infiltrating lymphocytes. Eur J Immunol 2005; 35: 1754-63.
2. Ju SA, Cheon SH, Park SM, Tam NQ, Kim YM, An WG, Kim BS,. Eradication of established renal cell carcinoma by a combination of 5-fluorouracil and anti-4-1BB monoclonal antibody in mice. Int J Cancer 2008; 122: 2784-90.
3. Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT,. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol 2011; 6: 1-10.
4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-64.
5. Zou W,. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295-307.
6. Oyagbemi AA, Saba AB, Azeez OI,. Molecular targets of [6]-gingerol: its potential roles in cancer chemoprevention. Biofactors 2010; 36: 169-78.
7. Shukla Y, Singh M,. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol 2007; 45: 683-90.
8. Lee SH, Cekanova M, Baek SJ,. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008; 47: 197-208.
9. Lee E, Surh YJ,. Induction of apoptosis in HL-60 cells by pungent vanilloids, 6-gingerol and 6-paradol. Cancer Lett 1998; 163-8.
10. Lee HS, Seo EY, Kang NE, Kim WK,. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem 2008; 19: 313-19.
11. Suzuki F, Kobayashi M, Komatsu Y, Kato A, Pollard RB,. Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res 1997; 17: 873-8.
12. Ju SA, Lee SC, Kwon TH, Heo SK, Park SM, Paek HN, Suh JH, Cho HR, Kwon B, Kwon BS, Kim BS,. Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes. Immunol Cell Biol 2005; 83: 344-51.
13. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78.
14. + ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 2010; 136: 1585-95.
15. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 18538-43.
16. Hiraoka N,. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol 2010; 15: 544-51.
17. Simpson JA, Al-Attar A, Watson NF, Scholefield JH, Ilyas M, Durrant LG,. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut 2010; 59: 926-33.
18. Syrbe U, Siveke J, Hamann A,. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 1999; 21: 263-85.
19. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG,. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med 1999; 190: 1123-34.
20. Munn DH, Mellor AL,. The tumor-draining lymph node as an immune-privileged site. Immunol Rev 2006; 213: 146-58.
21. Nagasawa H, Watanabe K, Inatomi H,. Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. Am J Chin Med 2002; 30: 195-205.
22. Kim M, Miyamoto S, Yasui Y, Oyama T, Murakami A, Tanaka T,. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int J Cancer 2009; 124: 264-71.
23. Kim SO, Chun KS, Kundu JK, Surh YJ,. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-κB and p38 MAPK in mouse skin. Biofactors 2004; 21: 27-31.
24. Yoshimi N, Wang A, Morishita Y, Tanaka T, Sugie S, Kawai K, Yamahara J, Mori H,. Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn J Cancer Res 1992; 83: 1273-78.
25. Habib SH, Makpol S, AbdulHamid NA, Das S, Ngah WZ, Yusof YA,. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo) 2008; 63: 807-13.
26. Jeong CH, Bode AM, Pugliese A, Cho YY, Kim HG, Shim JH, Jeon YJ, Li H, Jiang H, Dong Z,. [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res 2009; 69: 5584-91.
27. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491-4.
28. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-66.
29. + T cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61: 3932-6.
30. Saito M, Aoki D, Susumu N, Suzuki A, Suzuki N, Udagawa Y, Nozawa S,. Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. Int J Gynecol Cancer 2005; 15: 37-44.
31. Liotta F, Gacci M, Frosali F, Querci V, Vittori G, Lapini A, Santarlasci V, Serni S, Cosmi L, Maggi L, Angeli R, Mazzinghi B, et al. Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. BJU Int 2011; 107: 1500-6.
32. Qualls JE, Murray PJ,. Tumor macrophages protective and pathogenic roles in cancer development. Curr Top Dev Biol 2011; 94: 309-28.
33. Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P,. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int Immunopharmacol 2011; 11: 856-61.
34. Alvaro T, Lejeune M, Salvadõ MT, Bosch R, García JF, Jaén J, Banham AH, Roncador G, Montalbán C, Piris MA,. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11: 1467-73.
35. + cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J Immunother 2010; 33: 547-56.
36. Tan TT, Coussens LM,. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007; 19: 209-16.
37. Shah S, Divekar AA, Hilchey SP, Cho HM, Newman CL, Shin SU, Nechustan H, Challita-Eid PM, Segal BM, Yi KH, Rosenblatt JD,. Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int J Cancer 2005; 117: 574-86.
38. Gordon J, Holden HT, Segal S, Feldman M,. Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors. Int J Cancer 1982; 29: 351-7.
39. Schultz KR, Klarnet JP, Gieni RS, HayGlass KT, Greenberg PD,. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science 1990; 249: 921-3.
40. + T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol 2010; 184: 4006-16.
41. Pelletier MP, Edwardes MD, Michel RP, Halwani F, Morin JE,. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001; 44: 180-8.
42. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT,. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008; 14: 5220-7.
43. Gumus E, Erdamar S, Demirel G, Horasanli K, Kendirci M, Miroglu C,. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients. Int J Urol 2004; 11: 1070-7.
44. Schreiber H, Wu TH, Nachman J, Rowley DA,. Immunological enhancement of primary tumor development and its prevention. Semin Cancer Biol 2000; 10: 351-7.
45. Lee BS, Ko MS, Kim HJ, Kwak IS, Kim DH, Chung BW,. Separation of 6-gingerol from ginger (Zingiber officinale roscoe) and antioxidative activity. Kor J Biotechnol Bioeng 2006; 21: 484-88.